October 1 | 2020 Den sista patienten är registrerad med framgång i världens första interventionsstudie med 3D-mikrotumörer som vägledning för val av cancerbehandling. Read more
October 1 | 2020 Last patient successfully enrolled in the world’s first interventional trial with 3D microtumors as guide for choice of cancer treatment. Read more
June 25 | 2020 2cureX receives third payment from the EU’ Horizon 2020 SME- Instrument Program Read more
June 25 | 2020 2cureX receives third payment from the EU’ Horizon 2020 SME- Instrument Program Read more
June 16 | 2020 2cureX AB establishes collaboration with Scandion Oncology A/S and Erasmus Medical Centre, Rotterdam, in drug-resistant breast cancer patients Read more
June 16 | 2020 2cureX AB establishes collaboration with Scandion Oncology A/S and Erasmus Medical Centre, Rotterdam, in drug-resistant breast cancer patients Read more
May 29 | 2020 2cureX moves forward with the commercialization of IndiTreat by signing a new distributor agreement in Portugal Read more